Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

Notified -

Jenfi Surpasses US$100 Million in SME Financing Across Southeast Asia

Notified -

Hotel101 Global Reaches Record Single-Day Revenue Generation at 100% Occupancy in Hotel101 Madrid

Notified -

Amii Fuels Canada’s AI Momentum as Upper Bound Opens with 53% Growth and 11,000 Global Attendees

Notified -

Scientists discover over 1,100 new marine species in landmark Ocean Census

Notified -

Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026

Notified -

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures

Notified -

Bitget Introduces Delta Neutral Mode for Hedged Trading Strategies

Notified -

Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

Notified -

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact

Notified -

Bitget Enters Mexico Market With SAT and UIF Registration

Notified -

UGRO: urban-gro, Inc. (Nasdaq: UGRO) Locks Full Five-Franchise Lineup for Lanka Premier League Season 6; New Ownership Named for Kandy Royals, SC Jaffna Kings, and Colombo Kaps Ahead of July–August 2026 Tournament

Notified -